Ashley M Schnakenberg Martin1,2,3, Dae-Jin Kim1, Sharlene D Newman1, Hu Cheng1, William P Hetrick1,4, Ken Mackie1,4, Brian F O'Donnell1,4. 1. Department of Psychological and Brain Sciences and Program in Neuroscience, Indiana University, Bloomington, IN, USA. 2. Psychology Service, VA Connecticut Healthcare System, West Haven, CT, USA. 3. Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA. 4. Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Abstract
BACKGROUND: Cannabis use has been associated with abnormalities in cerebellar mediated motor and non-motor (i.e. cognition and personality) phenomena. Since the cerebellum is a region with high cannabinoid type 1 receptor density, these impairments may reflect alterations of signaling between the cerebellum and other brain regions. AIMS: We hypothesized that cerebellar-cortical resting-state functional connectivity (rsFC) would be altered in cannabis users, relative to their non-using peers. It was also hypothesized that differences in rsFC would be associated with cannabis use features, such as age of initiation and lifetime use. METHODS: Cerebellar-cortical and subcortical rsFCs were computed between 28 cerebellar lobules, defined by a spatially unbiased atlas template of the cerebellum, and individual voxels in the cerebral regions, in 41 regular cannabis users (20 female) and healthy non-using peers (N = 31; 18 female). We also investigated associations between rsFC and cannabis use features (e.g. lifetime cannabis use and age of initiation). RESULTS: Cannabis users demonstrated hyperconnectivity between the anterior cerebellar regions (i.e. lobule I-IV) with the posterior cingulate cortex, and hypoconnectivity between the rest of the cerebellum (i.e. Crus I and II, lobule VIIb, VIIIa, VIIIb, IX, and X) and the cortex. No associations were observed between features of cannabis use and rsFC. CONCLUSIONS: Cannabis use was associated with altered patterns of rsFC from the cerebellum to the cerebral cortex which may have a downstream impact on behavior and cognition.
BACKGROUND: Cannabis use has been associated with abnormalities in cerebellar mediated motor and non-motor (i.e. cognition and personality) phenomena. Since the cerebellum is a region with high cannabinoid type 1 receptor density, these impairments may reflect alterations of signaling between the cerebellum and other brain regions. AIMS: We hypothesized that cerebellar-cortical resting-state functional connectivity (rsFC) would be altered in cannabis users, relative to their non-using peers. It was also hypothesized that differences in rsFC would be associated with cannabis use features, such as age of initiation and lifetime use. METHODS: Cerebellar-cortical and subcortical rsFCs were computed between 28 cerebellar lobules, defined by a spatially unbiased atlas template of the cerebellum, and individual voxels in the cerebral regions, in 41 regular cannabis users (20 female) and healthy non-using peers (N = 31; 18 female). We also investigated associations between rsFC and cannabis use features (e.g. lifetime cannabis use and age of initiation). RESULTS: Cannabis users demonstrated hyperconnectivity between the anterior cerebellar regions (i.e. lobule I-IV) with the posterior cingulate cortex, and hypoconnectivity between the rest of the cerebellum (i.e. Crus I and II, lobule VIIb, VIIIa, VIIIb, IX, and X) and the cortex. No associations were observed between features of cannabis use and rsFC. CONCLUSIONS: Cannabis use was associated with altered patterns of rsFC from the cerebellum to the cerebral cortex which may have a downstream impact on behavior and cognition.
Authors: R I Block; D S O'Leary; R D Hichwa; J C Augustinack; L L Ponto; M M Ghoneim; S Arndt; J C Ehrhardt; R R Hurtig; G L Watkins; J A Hall; P E Nathan; N C Andreasen Journal: Neuroreport Date: 2000-03-20 Impact factor: 1.837
Authors: Matthew B Wall; Rebecca Pope; Tom P Freeman; Oliwia S Kowalczyk; Lysia Demetriou; Claire Mokrysz; Chandni Hindocha; Will Lawn; Michael Ap Bloomfield; Abigail M Freeman; Amanda Feilding; David Nutt; H Valerie Curran Journal: J Psychopharmacol Date: 2019-04-23 Impact factor: 4.153
Authors: R Andrew Sewell; Ashley Schnakenberg; Jacqueline Elander; Rajiv Radhakrishnan; Ashley Williams; Patrick D Skosnik; Brian Pittman; Mohini Ranganathan; D Cyril D'Souza Journal: Psychopharmacology (Berl) Date: 2012-11-24 Impact factor: 4.530